Peer Review
Cancer Imaging
ISSN 1470-7330
Search site with:PicoSearch


Content
Current Issue
Archive
Related Journals / Articles
Information
Aims and Scope
Editors and Board
Editorial Policy
Instructions for Authors
Copyright Transfer Form
Subscription Information
Advertising
Society
Aims
Membership
Annual Meeting
Communications
Send Email to ICIS
e-Med
Visit e-Med Web Site
Journals
Purchase
“To Promote Education in Cancer Imaging in the Multidisciplinary Management of Malignancy”

Home > Articles

Tumour volume measurement in head and neck cancer Open Access Article

Abstract

Tumour volume is a significant prognostic factor in the treatment of malignant head and neck tumours. Studies of laryngeal and pharyngeal tumours have shown tumour volume to be an important predictor for tumour recurrence. Some studies (for instance nasopharyngeal carcinoma) have shown through multivariate modelling that tumour volume is a dominant covariate that overwhelms T stage, N stage and stage group. The results of these studies have prompted several investigators to suggest the inclusion of tumour volume as an additional prognostic factor in future revisions of the TNM staging system. This paper briefly reviews the TNM system as a staging tool, the measurement of tumour volume and how tumour volume could possibly be incorporated in the system or used as an additional prognostic factor.

Author

Vincent F.H. Chong

Contact Details

Corresponding address:
Vincent F.H. Chong, Department of Diagnostic Radiology, National University Hospital,
5 Lower Kent Ridge Road, Singapore 119074

Reference

ICIS Cancer Imaging Volume 7 Special Issue A
DOI: 10.1102/1470-7330.2007.9002

Date Posted

1 October 2007


Open Access Article Open Access is provided for this article.

Print PDF

Size

49.98 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):

1 second

ADSL 512Kb/s (Broadband):

1 second

64 Kb/s (ISDN):

6 seconds

33.3 Kb/s (Typical Modem):

12 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 66356, London, E14 1GW. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.

© 2000-2010 International Cancer Imaging Society